Platform could improve ALS and FTD trial endpoints
Cumulus Neuroscience, a global digital health company, has published final results from its first-in-class CNS-102 study in Scientific Reports. The study was conducted in collaboration with the PRECISIONALS initiative, a Research Ireland academic–industry collaboration hosted by Trinity College Dublin. The paper, titled “Longitudinal cognitive assessment using the Cumulus NeuLogiq Platform in… Read More